Back to top
more

SeaSpine Holdings Corporation (SPNE)

(Delayed Data from NSDQ)

$15.36 USD

15.36
60,781

+0.73 (4.99%)

Updated May 3, 2019 04:00 PM ET

After-Market: $15.40 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

SeaSpine Holdings (SPNE) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

SeaSpine (SPNE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

What's in the Cards for CVS Health (CVS) in Q3 Earnings?

CVS Health's (CVS) Q3 earnings might have been affected by issues like lower prescription and soft front store volume due to decline in provider visits.

National Vision (EYE) to Report Q3 Earnings: What's in Store?

National Vision's (EYE) contact lens revenue growth is expected to have remained impressive in Q3 on lesser impact of store closures.

Tivity Health (TVTY) to Report Q3 Earnings: What's in Store?

Strength in digital branding is likely to have aided Tivity Health's (TVTY) performance in the third quarter of 2020 amid coronavirus-led economic doldrums.

STERIS (STE) to Report Q2 Earnings: What's in the Cards?

Within Life Sciences, STERIS (STE) might have registered benefit from pharma customers on growing vaccines and biologics businesses in Q2.

What Makes SeaSpine Holdings (SPNE) a Strong Momentum Stock: Buy Now?

Does SeaSpine Holdings (SPNE) have what it takes to be a top stock pick for momentum investors? Let's find out.

SeaSpine's Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in SeaSpine.

Moving Average Crossover Alert: SeaSpine Holdings

SeaSpine Holdings is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

SeaSpine Holdings (SPNE) Reports Q2 Loss, Tops Revenue Estimates

SeaSpine (SPNE) delivered earnings and revenue surprises of 28.57% and 36.82%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate SeaSpine Holdings (SPNE) to Report a Decline in Earnings: What to Look Out for

SeaSpine (SPNE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SeaSpine Holdings (SPNE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

SeaSpine (SPNE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SeaSpine Holdings Enters Oversold Territory

SeaSpine Holdings has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

SeaSpine Sees Hammer Chart Pattern: Time to Buy?

SeaSpine Holdings has been struggling lately, but the selling pressure may be coming to an end soon.

SeaSpine Holdings (SPNE) Reports Q4 Loss, Tops Revenue Estimates

SeaSpine (SPNE) delivered earnings and revenue surprises of -2.27% and 0.32%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Edwards Lifesciences (EW) Q4 Earnings Lag, Sales Top Estimates

Edwards Lifesciences (EW) witnesses growth in TAVR procedures, led by strong therapy adoption across all geographies, particularly in the United States.

ResMed (RMD) Q2 Earnings Beat Estimates, Margins Expand

ResMed (RMD) exhibits robust growth in the second quarter of fiscal 2020, fueled by the strong performance of both its segment.

IDEXX (IDXX) Q4 Earnings Top Estimates, Revenues Grow Y/Y

The year-over-year upside in IDEXX's (IDXX) revenues was primarily driven by strong global gains in CAG Diagnostics' recurring revenues.

CONMED (CNMD) Earnings and Revenues Beat Estimates in Q4

CONMED's (CNMD) fourth-quarter earnings gain from higher revenues and strong performance in General Surgery segment. However, high long-term debt remains a concern.

Quest Diagnostics (DGX) Q4 Earnings Beat, Margins Strong

We are upbeat about Quest Diagnostics' (DGX) expanded network access, which assists the company to expedite volume growth in Q4.

Hologic (HOLX) Q1 Earnings Meet, Revenues Beat Estimates

Hologic (HOLX) exhibits robust growth in first-quarter fiscal 2020, fueled by strong performance in the majority of its segments.

Illumina (ILMN) Q4 Earnings Beat Estimates, Margins Expand

Illumina (ILMN) exhibits robust growth in the fourth quarter of fiscal 2019, fueled by strong performance of the sequencing consumable segment.

Thermo Fisher (TMO) Q4 Earnings Top, Organic Growth Solid

We are upbeat that two of Thermo Fisher's (TMO) four business segments deliver strong year-over-year revenue growth in Q4.

AmerisourceBergen (ABC) Q1 Earnings Beat, Revenues Miss

AmerisourceBergen's (ABC) Q1 earnings benefit from higher revenues, segmental growth and strong fiscal 2020 outlook.

Align Technology (ALGN) Earnings Beat in Q4, Margins Rise

We are upbeat about Align Technology's (ALGN) continued momentum in Invisalign volumes across all geographies during Q4.

Stryker (SYK) Q4 Earnings and Revenues Surpass Estimates

Stryker's (SYK) fourth-quarter earnings gain from higher revenues, solid segmental performance and strong organic growth across businesses benefit.